The enrolled measure would let schools and camps use approved epinephrine devices for emergencies, while students need written approval and a backup dose to carry one.
Students in public school districts and chartered nonpublic schools may use an approved epinephrine device for a severe allergic reaction at school or school events, if the required approvals and backup dose are in place.
Public school districts and covered camps may keep epinephrine devices for emergencies. They must set rules for storage, authorized users, training, and calling for emergency medical help after a dose is used.
The state pharmacy board must name approved devices that deliver a measured dose of epinephrine, including nasal sprays and any other devices it designates.
A student may possess and use an epinephrine delivery system to treat anaphylaxis. This applies to students in public school districts and chartered nonpublic schools, at school and at school activities or events. A prescriber must give written approval, and a parent, guardian, or caregiver must also approve if the student is a minor. The principal or school nurse must receive the approvals and a backup dose from the parent, guardian, caregiver, or adult student. After a student uses the device, or a school employee gives a dose through the student's device, an employee must immediately call emergency medical services.
Public school districts and covered camps may obtain epinephrine delivery systems for emergencies and must set rules for their storage and use. This applies to public school districts and residential or child day camps, including certain camps run by local governments. They may obtain devices through a prescriber's supply or prescription, or through a prescriber-issued protocol. Before adopting rules, the district superintendent or camp must consult a prescriber. The rules must cover storage, replacement, disposal, who may use a device, any required training, and when to call emergency medical services.
The state pharmacy board must adopt rules naming approved devices or products that deliver a measured dose of epinephrine by any route. The text names autoinjectors and nasal sprays, and allows the board to designate other devices or products. The devices or products designated must be approved by the U.S. Food and Drug Administration for giving a premeasured dose of epinephrine.
No hearings or votes scheduled.